Sarcoma  >>  celecoxib oral  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
celecoxib oral / Generic mfg.
NCT00061893: Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of Tumors

Completed
2
38
Canada, US, RoW
celecoxib, cyclophosphamide, doxorubicin hydrochloride, etoposide, ifosfamide, vinblastine sulfate, vincristine sulfate, conventional surgery, radiation therapy, MESNA, Filgrastim, G-CSF
Children's Oncology Group, National Cancer Institute (NCI)
Sarcoma
04/08
12/13
NCT00357500: Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer

Completed
2
101
US
celecoxib, cyclophosphamide, etoposide, fenofibrate, thalidomide
Dana-Farber Cancer Institute, National Cancer Institute (NCI), Boston Children's Hospital
Central Nervous System Tumor, Pediatric, Leukemia, Lymphoma, Neuroblastoma, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
02/13
12/13
NCT02054104: Adjuvant Tumor Lysate Vaccine and Iscomatrix With or Without Metronomic Oral Cyclophosphamide and Celecoxib in Patients With Malignancies Involving Lungs, Esophagus, Pleura, or Mediastinum

Terminated
1/2
21
US
H1299 cell lysates, Cyclophosphamide, Cytoxan, Celecoxib, Celebrex, Iscomatrix adjuvant
National Cancer Institute (NCI)
Thoracic Sarcomas, Thorasic Cancers, Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura, Sarcoma, Melanoma
06/15
06/15

Download Options